AstraZeneca Collaborations Moving From “Deals” To “Relationships”
This article was originally published in The Pink Sheet Daily
Fox Chase Cancer Center’s Weeks concurs that umbrella agreements with pharma and biotech companies are becoming more common.
You may also be interested in...
The Solicitor General says the Supreme Court should not hear the Commission's appeal of a case brought against Schering-Plough regarding a generic drug settlement.
Tests are currently available to identify patient responders, but clinicians need guidance on how to adjust dosing for them, the HHS Secretary's Advisory Committee on Genetics, Health & Society agreed.
One example of the value of genotyping is Genentech's Herceptin, committee members agreed.